Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice ; volume:7 ; number:1 ; day:7 ; month:5 ; year:2019 ; pages:1-9 ; date:12.2019
Acta Neuropathologica Communications ; 7, Heft 1 (7.5.2019), 1-9, 12.2019
- Urheber
-
Skachokova, Zhiva
Martinisi, Alfonso
Flach, Martin
Sprenger, Frederik
Naegelin, Yvonne
Steiner-Monard, Viviane
Sollberger, Marc
Monsch, Andreas U.
Goedert, Michel
Tolnay, Markus
Winkler, David T.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-019-0725-3
- URN
-
urn:nbn:de:101:1-2019080823103286168748
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Skachokova, Zhiva
- Martinisi, Alfonso
- Flach, Martin
- Sprenger, Frederik
- Naegelin, Yvonne
- Steiner-Monard, Viviane
- Sollberger, Marc
- Monsch, Andreas U.
- Goedert, Michel
- Tolnay, Markus
- Winkler, David T.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy
Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease
Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer’s disease: a pilot study
Modeling Alzheimer’s disease in transgenic rats
Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy
Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease
Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer’s disease: a pilot study
Modeling Alzheimer’s disease in transgenic rats
Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy
Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease
Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer’s disease: a pilot study
Modeling Alzheimer’s disease in transgenic rats
Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease